Alcon Announces FDA Approval For BRYTLY Redness Relief Eye Drops, Expanding Over The Counter Eye Care Portfolio.

• One drop works to significantly reduce redness, with results lasting up to 12 hours1
• Lasts up to 50% longer than Lumify1-2,*
• Expands Alcon's portfolio of consumer eye care solutions and will be available in major retailers nationwide and online in the coming months

Alcon (NYSE:ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that the U.S. Food and Drug Administration (FDA) has approved BRYTLY® Redness Reliever Eye Drops. With one drop, BRYTLY works in just one minute to significantly reduce redness and delivers up to 12 hours of whiter, brighter-looking eyes.1 Additionally, BRYTLY lasts up to 50% longer than Lumify.1-2,* The approval brings a differentiated new option to the over the counter (OTC) redness-relief category and expands Alcon’s portfolio of trusted consumer eye care products.